CIENCIASMEDICASNEWS: Join the 3rd Microbiome Movement - Drug Development Summit Europe 2019

jueves, 10 de enero de 2019

Join the 3rd Microbiome Movement - Drug Development Summit Europe 2019

	January 10, 2019
	Microbiology
	The latest microbiology news from the AZoNetwork

Join the 3rd Microbiome Movement - Drug Development Summit Europe 2019
An industry-defining forum (28-30 January | Paris, France) to help discover, develop and deliver the next generation of microbiome-based therapeutic and diagnostic candidates to market. Set to tackle the greatest scientific, regulatory, clinical, manufacturing and commercialisation challenges across the entire drug development value chain, this meeting will showcase leading industry case studies focused on enhancing the application of novel technologies to standardise results, accelerate target discovery and optimise the translation of microbiome research into safe and effective therapeutic products.

Register today for the best possible rate: Save 10% with discount code 9999NMLS.

Porous Load Sterilizers for Microbiological Applications

Designed to combat demanding sterile supplies department workloads, LTE porous load sterilizers are simple to operate and can be customized to meet customer-specific specifications. They are available in a variety of sizes, both single entry or passthrough. Only the best quality components are utilized in the construction of every LTE sterilizer. Ongoing service and maintenance costs are kept low because of the non-proprietary parts used.

Learn More

Bacteria on the International Space Station are adapting to survive, not to harm

New research has revealed that microbes stranded in the International Space Station (ISS) have different genes from the equivalent bacteria on Earth. Whilst there have been many concerns about these microbes forming a new generation of “superbugs”, it now appears that the differences are making the bacteria more able to withstand the harsh conditions of space, rather than increasing pathogenicity.

	Scientist proves role of microbiome in obesity New research presented by Dr. Christoph Thaiss in his award winning essay for the “Science and SciLifeLab Prize for Young Scientists” describes several bacterial metabolites in the human gut are modified during obesity.

	RNA sequencing offers novel insights into the microbiome By helping scientists to understand how tRNA changes dynamically within microbiomes, the novel sequencing strategy will provide much better insight into how microbiomes found in nature react to environmental changes such as temperature variation or changes in nutrient availability.

	Gut microbes play important role in protecting against arsenic toxicity, research shows Research conducted at Montana State University shows that microbes in the human gut play an important role in protecting against arsenic toxicity, a problem that affects an estimated 200 million people who are exposed to arsenic through contaminated drinking water.

	Research suggests a promising therapeutic target to treat or prevent metabolic disorders Research led by Suresh Alahari, PhD, Fred Brazda Professor of Biochemistry and Microbiology at LSU Health New Orleans, suggests a novel protein may be a promising therapeutic target to treat or prevent metabolic disorders.

	A new frontier in research to better understand gut microbiome and digestive health Research on the gut microbiome is one of the most promising areas of science today. In a new special issue of Clinical Gastroenterology and Hepatology, the American Gastroenterological Association has taken the deep-dive into the gut microbiome that both scientists and the public are looking for to help them better understand the effects of the microbiome on health and disease.